Matthew J. Berberich

756 total citations
15 papers, 344 citations indexed

About

Matthew J. Berberich is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Matthew J. Berberich has authored 15 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Virology. Recurrent topics in Matthew J. Berberich's work include Protein Degradation and Inhibitors (5 papers), HIV Research and Treatment (4 papers) and Immunotherapy and Immune Responses (3 papers). Matthew J. Berberich is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), HIV Research and Treatment (4 papers) and Immunotherapy and Immune Responses (3 papers). Matthew J. Berberich collaborates with scholars based in United States, Germany and South Korea. Matthew J. Berberich's co-authors include Peter K. Sorger, Nathanael S. Gray, Marian Kalocsay, Robert A. Everley, Sylvie Le Gall, Nicholas Kwiatkowski, Tinghu Zhang, Baishan Jiang, Yang Gao and Jianwei Che and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Matthew J. Berberich

15 papers receiving 342 citations

Peers

Countries citing papers authored by Matthew J. Berberich

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Berberich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Berberich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Berberich more than expected).

Fields of papers citing papers by Matthew J. Berberich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Berberich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Berberich. The network helps show where Matthew J. Berberich may publish in the future.

Co-authorship network of co-authors of Matthew J. Berberich

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Berberich. A scholar is included among the top collaborators of Matthew J. Berberich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Berberich. Matthew J. Berberich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Proteomic profiling across breast cancer cell lines and models 2023 ·Scientific Data ·Marian Kalocsay, Matthew J. Berberich, Robert A. Everley, Maulik K. Nariya, Mirra Chung, Benjamin L. Gaudio, (unknown), Gary A. Bradshaw, (unknown), Marc Hafner, Peter K. Sorger, Caitlin E. Mills, Kartik Subramanian	6
2	Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions 2023 ·Journal of Medicinal Chemistry ·Yang Gao, Baishan Jiang, (unknown), Matthew J. Berberich, Jianwei Che, Katherine A. Donovan, John M. Hatcher, (unknown), Nicholas Kwiatkowski, Yingpeng Liu, (unknown), (unknown), (unknown), Radosław P. Nowak, Tinghu Zhang, Eric S. Fischer, Nathanael S. Gray, Lyn H. Jones	31
3	Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations 2022 ·Molecular Systems Biology ·(unknown), Dan Lü, Marian Kalocsay, Matthew J. Berberich, (unknown), Ashwini Jambhekar, Galit Lahav	24
4	Discovery and resistance mechanism of a selective CDK12 degrader 2021 ·Nature Chemical Biology ·Baishan Jiang, Yang Gao, Jianwei Che, Wenchao Lu, Ines H. Kaltheuner, Ruben Dries, Marian Kalocsay, Matthew J. Berberich, Jie Jiang, Inchul You, Nicholas Kwiatkowski, Kristin M. Riching, Danette L. Daniels, Peter K. Sorger, Matthias Geyer, Tinghu Zhang, Nathanael S. Gray	96
5	Impact of Zika virus on the human type I interferon osteoimmune response 2020 ·Cytokine ·Arnaud Drouin, (unknown), (unknown), Sharon Liu, Joshua P. Katz, (unknown), (unknown), (unknown), (unknown), (unknown), Matthew J. Berberich, Marian Kalocsay, Fernando Pozzi Semeghini Guastaldi, Nicolas Salvadori, Maria J. Troulis, Dahlene N. Fusco	3
6	A dynamic view of the proteomic landscape during differentiation of ReNcell VM cells, an immortalized human neural progenitor line 2019 ·Scientific Data ·Yuyu Song, Kartik Subramanian, Matthew J. Berberich, Steven Rodriguez, Isabel Latorre, (unknown), Robert A. Everley, Mark W. Albers, Timothy J. Mitchison, Peter K. Sorger	36
7	Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome 2019 ·Cell chemical biology ·(unknown), Deepak Gurbani, Guangyan Du, Robert A. Everley, Christopher M. Browne, A. Chaikuad, Li Tan, Martin Schröder, Sudershan Reddy Gondi, Scott B. Ficarro, Taebo Sim, Nam Doo Kim, Matthew J. Berberich, Stefan Knapp, Jarrod A. Marto, Kenneth D. Westover, Peter K. Sorger, Nathanael S. Gray	51
8	Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity 2019 ·Cell chemical biology ·Fleur M. Ferguson, Zainab M. Doctor, Scott B. Ficarro, Christopher M. Browne, Jarrod A. Marto, Jared L. Johnson, Tomer M. Yaron, Lewis C. Cantley, Nam Doo Kim, Taebo Sim, Matthew J. Berberich, Marian Kalocsay, Peter K. Sorger, Nathanael S. Gray	19
9	The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner 2019 ·The Journal of Immunology ·Julie Boucau, (unknown), (unknown), Christopher S. Carlin, (unknown), Matthew J. Berberich, Sylvie Le Gall	4
10	MS3-IDQ: Utilizing MS3 Spectra beyond Quantification Yields Increased Coverage of the Phosphoproteome in Isobaric Tag Experiments 2018 ·Journal of Proteome Research ·Matthew J. Berberich, João A. Paulo, Robert A. Everley	5
11	Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses 2016 ·Journal of Virology ·Marijana Ručević, (unknown), Julie Boucau, (unknown), (unknown), Matthew J. Berberich, Bruce D. Walker, Angelika B. Riemer, Sylvie Le Gall	14
12	HIV Protease Inhibitor–Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation 2016 ·The Journal of Immunology ·(unknown), Marijana Ručević, Matthew J. Berberich, (unknown), (unknown), Julie Boucau, Sylvie Le Gall	16
13	Variable Processing and Cross-presentation of HIV by Dendritic Cells and Macrophages Shapes CTL Immunodominance and Immune Escape 2015 ·PLoS Pathogens ·(unknown), Ellen Duong, Nicole Y. Lai, Matthew J. Berberich, (unknown), (unknown), (unknown), Hang Su, (unknown), Sylvie Le Gall	31
14	In vitro evaluation of digestive and endolysosomal enzymes to cleave CML‐modified Ara h 1 peptides 2015 ·Food Science & Nutrition ·Christopher P. Mattison, (unknown), Matthew J. Berberich, Si‐Yin Chung, (unknown), Sylvie Le Gall, Casey C. Grimm	7
15	Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells 2015 ·Journal of Virus Eradication ·Julie Boucau, (unknown), (unknown), Matthew J. Berberich, Sylvie Le Gall	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact